Abstract:A sensitive and specific radioimmunoprécipitation assay was developed for the detection and analysis of
anti-HIV antibody response in human sera with the use of 125I-labelled purified HIV proteins with subsequent
sodium-dodecylsulfate gel electrophoresis (125I-RIPA). The 125I-RIPA was shown to be as specific but at least 1 log
more sensitive with respect to the detection of gp41^env and p24^gag than the immunoblot analysis as tested in serum
samples from several risk groups. Sequential sera were obtained from … Show more
“…In brief, 50-l solutions of phosphate-buffered saline (PBS) containing either 20 g of peptides or 5 g of protein was used for labeling with Na-125 I using chloramine T for 30 s (27). The radiolabeled preparations were purified from free iodine by dialysis and subsequently aliquoted in the presence of protease inhibitor phenylmethylsulfonyl fluoride and bovine serum albumin (BSA; fraction V; Sigma) in a final concentration of 0.1% and stored until use at Ϫ20°C.…”
Development of disease is extremely rare in chimpanzees when inoculated with either T-cell-line-adapted neutralization-sensitive or primary human immunodeficiency virus type 1 (HIV-1), at first excluding a role for HIV-1 neutralization sensitivity in the clinical course of infection. Interestingly, we observed that short-term in vivo and in vitro passage of primary HIV-1 isolates through chimpanzee peripheral blood mononuclear cells (PBMC) resulted in a neutralization-sensitive phenotype. Furthermore, an HIV-1 variant reisolated from a chimpanzee 10 years after experimental infection was still sensitive to neutralization by soluble CD4, the CD4 binding site recognizing antibody IgG1b12 and autologous chimpanzee serum samples, but had become relatively resistant to neutralization by polyclonal human sera and neutralizing monoclonal antibodies. The initial adaptation of HIV-1 to replicate in chimpanzee PBMC seemed to coincide with a selection for viruses with low replicative kinetics. Neither coreceptor usage nor the expression level of CD4, CCR5, or CXCR4 on chimpanzee PBMC compared to human cells could explain the phenotypic changes observed in these chimpanzee-passaged viruses. Our data suggest that the increased neutralization sensitivity of HIV-1 after replication in chimpanzee cells may in part contribute to the long-term asymptomatic HIV-1 infection in experimentally infected chimpanzees.
“…In brief, 50-l solutions of phosphate-buffered saline (PBS) containing either 20 g of peptides or 5 g of protein was used for labeling with Na-125 I using chloramine T for 30 s (27). The radiolabeled preparations were purified from free iodine by dialysis and subsequently aliquoted in the presence of protease inhibitor phenylmethylsulfonyl fluoride and bovine serum albumin (BSA; fraction V; Sigma) in a final concentration of 0.1% and stored until use at Ϫ20°C.…”
Development of disease is extremely rare in chimpanzees when inoculated with either T-cell-line-adapted neutralization-sensitive or primary human immunodeficiency virus type 1 (HIV-1), at first excluding a role for HIV-1 neutralization sensitivity in the clinical course of infection. Interestingly, we observed that short-term in vivo and in vitro passage of primary HIV-1 isolates through chimpanzee peripheral blood mononuclear cells (PBMC) resulted in a neutralization-sensitive phenotype. Furthermore, an HIV-1 variant reisolated from a chimpanzee 10 years after experimental infection was still sensitive to neutralization by soluble CD4, the CD4 binding site recognizing antibody IgG1b12 and autologous chimpanzee serum samples, but had become relatively resistant to neutralization by polyclonal human sera and neutralizing monoclonal antibodies. The initial adaptation of HIV-1 to replicate in chimpanzee PBMC seemed to coincide with a selection for viruses with low replicative kinetics. Neither coreceptor usage nor the expression level of CD4, CCR5, or CXCR4 on chimpanzee PBMC compared to human cells could explain the phenotypic changes observed in these chimpanzee-passaged viruses. Our data suggest that the increased neutralization sensitivity of HIV-1 after replication in chimpanzee cells may in part contribute to the long-term asymptomatic HIV-1 infection in experimentally infected chimpanzees.
“…After dialysis against PBS the extracts and membrane preparations from subcellular neutrophil fractions (pools a, fl, and y) were supplemented with NaCI, SDS, and Triton X-100 to final concentrations of 0.5 M, 0.5% (wt/vol), and 1% (wt/vol), respectively. The samples thus obtained were radiolabeled with 1251I by the iodogen method (31) and assayed by immunoprecipitation with the protein A method described by Huisman et al (32). Immunoprecipitation with sheep anti-cathepsin G was performed with antibodies linked covalently to CNBr-activated Sepharose 4B.…”
“…We believe that the WB assay in these cases of atypical anti-p248a® reactivity recognizes crossreacting antibodies against a common epitope or epitopes, which may be enhanced by the changes in structure of the viral proteins during the WB procedures, and therefore are hardly found with 125I-RIPA, which in our hands is as sensitive as WB in detecting true anti-p24gag antibodies [13,15]. This is supported by the specific inhibition of the reactivity with infected H9 cells.…”
Section: Donors With Anti-p24gasmentioning
confidence: 51%
“…Additional HIV-1 antibody testing was performed with HIV-1 125I radioimmunoprécipitation assay (RIPA) and HIV-1 WB devel oped by the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, the Netherlands (WB-CLB) [12,15] and HIV-1 WB by Diagnostic Pasteur (Mames-la-Coquette, France) (WB-Pasteur).…”
During a follow-up period of 23-40 months, 7 regular blood donors had persistently, and 4 had
intermittently indeterminate anti-p24^gag reactivity in human immunodeficiency virus (HIV)-l Western Blot. Serological
testing and viral cultures revealed that these donors had no signs of infection for HIV-1, HIV-2, human T-cell
lymphotropic virus (HTLV)-4, and HTLV-1. Extensive interviewing and physical examination of these donors
revealed neither risk factors, nor signs of HIV infection in the tested donors. Ten recipients, who were transfused
with blood products from 6 of these 11 anti-p24^gag-positive donors, were traced back. Six months after transfusion,
no serological or clinical signs of HIV-1, HIV-2, or HTLV-1 infection were observed in these patients. It is concluded
that blood donors with persistent or intermittent anti-p24^gag reactivity in HIV-1 Western Blot, without development
of antibodies to other HIV-encoded proteins in later blood samples, do not transmit the described retroviruses to
transfused patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.